Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › ME › Skowhegan › NPI 1174549133
Transport

Redington-Fairview General Hospital

Redington-Fairview General Hospital was paid $5.97M by Medicaid between Jan 2018 and Dec 2024, across 396 billing codes. Its largest line is 99285, emergency room visit (most serious) — 13% of everything it billed.

33Billing provider infoREDINGTON-FAIRVIEW GENERAL HOSPITAL
SKOWHEGAN, ME 04976
33aNPI1174549133assigned 07/14/2006
33bProvider typeLand Ambulance
28Total paid$5.97M
24GClaims1,171,932
24DCodes billed396
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Land Ambulance providers in Maine

Rank by total paid#2 of 86
Median peer was paid$150K
This provider vs. median40×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018217,536$1.12M
2019226,978$1.23M
2020138,852$887K
2021142,710$735K
2022143,516$724K
2023153,748$655K
2024incomplete148,592$621K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 13% 13,576 10,361 $786K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 34,388 23,556 $701K
74177 Computed tomography, abdomen and pelvis; with contrast material 10% 4,979 4,248 $607K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 6.1% 55,374 35,417 $362K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5.5% 96,896 55,623 $327K
70450 Computed tomography, head or brain; without contrast material 4.7% 4,521 3,920 $281K
71275 Computed tomographic angiography, chest, with contrast material 3.3% 1,068 925 $196K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 3.2% 1,861 1,190 $194K
74176 Computed tomography, abdomen and pelvis; without contrast material 3.1% 1,551 1,425 $182K
71046 Radiologic examination, chest; 2 views 2.4% 10,842 8,434 $146K
71045 Radiologic examination, chest; single view 2.4% 6,525 5,155 $140K
G0378 Hospital observation service, per hour 2.3% 881 835 $135K
384 more codes
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.2% 16,095 $133K
99214 Doctor's office visit, returning patient (more involved) 2.2% 29,290 $131K
71260 Computed tomography, thorax, diagnostic; with contrast material 2.0% 1,591 $122K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.6% 18,640 $98K
72125 Computed tomography, cervical spine; without contrast material 1.6% 1,690 $95K
A0427 Emergency ambulance ride, advanced life support 1.5% 3,638 $91K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1.4% 7,122 $84K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) 1.4% 3,227 $83K
A0425 Ground mileage, per statute mile 1.4% 11,163 $82K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 3,411 $70K
A0429 Emergency ambulance ride, basic life support <1% 3,194 $59K
80053 Comprehensive metabolic panel <1% 28,236 $48K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 7,872 $34K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 11,186 $33K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,162 $32K
99232 Hospital visit by a doctor, follow-up day <1% 1,390 $31K
73502 <1% 740 $28K
97161 <1% 2,093 $27K
73030 <1% 1,856 $27K
71250 <1% 313 $26K
73564 <1% 1,836 $25K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 510 $25K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,283 $23K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 8,351 $21K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,715 $20K
73630 <1% 2,157 $19K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,264 $16K
73610 <1% 2,081 $16K
20610 <1% 888 $15K
97113 <1% 1,286 $15K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 3,997 $13K
73130 <1% 1,446 $13K
97162 <1% 1,211 $13K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 2,609 $13K
99215 Doctor's office visit, returning patient (complex) <1% 1,764 $12K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,689 $11K
93017 <1% 248 $11K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,798 $10K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 4,086 $10K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,709 $9K
99203 Doctor's office visit, new patient (routine) <1% 3,400 $9K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 153 $8K
80048 Basic metabolic panel (calcium, ionized) <1% 5,288 $8K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 54 $8K
99070 <1% 626 $8K
97165 <1% 521 $7K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 15,876 $7K
93971 <1% 175 $7K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 364 $7K
99204 Doctor's office visit, new patient (more involved) <1% 1,960 $7K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 6,258 $7K
73110 <1% 901 $6K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 43,042 $6K
36591 <1% 645 $6K
J3490 Unclassified drugs <1% 26,915 $6K
94664 <1% 1,576 $5K
84443 Thyroid stimulating hormone (TSH) <1% 10,994 $5K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 942 $5K
36415 Collection of venous blood by venipuncture <1% 62,915 $5K
83036 Hemoglobin; glycosylated (A1C) <1% 10,628 $4K
94010 <1% 475 $4K
99442 <1% 1,403 $4K
72110 <1% 156 $4K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 52 $4K
74018 <1% 386 $4K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 268 $3K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 111 $3K
72100 <1% 226 $3K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 53 $3K
99222 Initial hospital care, per day, moderate complexity <1% 322 $3K
11721 <1% 485 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 79 $3K
J3370 Injection, vancomycin hcl, 500 mg <1% 151 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,888 $2K
90715 <1% 2,431 $2K
36600 <1% 382 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,636 $2K
99441 <1% 1,037 $2K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 6,183 $2K
99495 <1% 60 $2K
99443 <1% 378 $2K
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit <1% 2,480 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,713 $2K
84484 <1% 9,332 $2K
J3372 Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg <1% 254 $2K
83735 <1% 16,008 $2K
97597 <1% 149 $2K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 37 $2K
69209 <1% 227 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,423 $2K
83880 <1% 3,065 $1K
J2060 Injection, lorazepam, 2 mg <1% 2,010 $1K
82728 <1% 3,222 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,154 $1K
85610 <1% 9,985 $1K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 29 $1K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 3,206 $1K
82607 <1% 2,705 $1K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 5,495 $1K
80061 Lipid panel <1% 9,752 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,011 $1K
76642 <1% 67 $1K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 1,030 $1K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 1,082 $1K
99239 Hospital discharge day management, more than 30 minutes <1% 41 $1K
99219 <1% 232 $1K
74022 <1% 37 $1K
87088 <1% 5,897 $1K
76536 <1% 55 $1K
82803 <1% 1,409 $1K
87186 <1% 3,288 $990.00
87040 <1% 2,602 $987.46
J7050 Infusion, normal saline solution, 250 cc <1% 2,969 $957.70
J1650 Injection, enoxaparin sodium, 10 mg <1% 244 $947.49
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,486 $912.50
99217 <1% 281 $905.71
J3475 Injection, magnesium sulfate, per 500 mg <1% 351 $875.19
80305 <1% 6,529 $807.65
94760 <1% 612 $801.36
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 484 $799.43
80050 General health panel <1% 2,751 $770.22
80076 <1% 848 $764.68
83605 <1% 3,204 $762.86
83690 <1% 8,263 $756.89
86901 <1% 2,124 $743.51
A6216 Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 122 $734.37
86140 <1% 6,576 $695.63
84466 <1% 2,073 $683.75
99050 <1% 2,226 $676.00
J2270 Injection, morphine sulfate, up to 10 mg <1% 450 $660.22
82565 <1% 13,012 $656.62
83615 <1% 3,496 $652.79
82310 <1% 12,758 $640.74
81001 <1% 7,824 $600.42
73590 <1% 80 $582.16
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 851 $576.60
87077 <1% 3,501 $564.72
82374 <1% 12,596 $559.81
82247 <1% 11,120 $558.21
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 10,273 $543.89
82435 <1% 12,600 $538.54
86803 <1% 2,355 $512.35
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,752 $497.99
86920 <1% 20 $492.40
00731 <1% 26 $478.37
81003 <1% 7,965 $478.25
83540 <1% 2,486 $472.82
84460 <1% 11,222 $472.72
73560 <1% 27 $472.38
84450 <1% 11,203 $458.39
99490 Ccm add 20min <1% 72 $449.07
84075 <1% 11,134 $441.60
84520 <1% 12,757 $438.77
84295 <1% 12,615 $432.48
82962 <1% 3,919 $422.14
86900 <1% 2,078 $422.04
84132 <1% 12,666 $413.44
A6250 Skin sealants, protectants, moisturizers, ointments, any type, any size <1% 308 $397.71
85730 <1% 3,871 $397.54
73140 <1% 126 $361.55
93016 <1% 218 $345.96
84155 <1% 11,222 $337.38
97035 <1% 131 $336.84
82040 <1% 11,206 $332.46
73080 <1% 27 $327.39
82043 <1% 1,425 $326.18
82550 <1% 1,810 $323.03
84100 <1% 4,044 $311.63
80306 <1% 3,106 $302.98
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 5,483 $302.52
93976 <1% 12 $300.63
85379 <1% 2,324 $296.97
94060 <1% 22 $296.57
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,126 $292.18
84439 <1% 2,565 $290.88
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,543 $287.48
85652 <1% 5,096 $285.98
A4565 Slings <1% 121 $278.07
82746 <1% 1,016 $267.51
J1940 Injection, furosemide, up to 20 mg <1% 145 $263.85
87070 <1% 3,090 $250.74
85027 <1% 2,300 $239.54
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 4,808 $237.51
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 133 $234.91
93018 <1% 218 $231.61
87634 <1% 841 $228.76
76775 <1% 13 $225.60
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 5,620 $225.17
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,383 $223.10
82150 <1% 581 $221.63
86886 <1% 172 $213.96
J1010 Injection, methylprednisolone acetate, 1 mg <1% 60 $206.07
77063 Screening digital breast tomosynthesis, bilateral <1% 2,398 $199.54
00812 <1% 31 $190.42
99238 Hospital discharge day management, 30 minutes or less <1% 13 $188.80
72050 <1% 12 $186.67
82248 <1% 1,960 $181.83
77067 Screening mammography, bilateral, including computer-aided detection <1% 3,125 $172.59
J3480 Injection, potassium chloride, per 2 meq <1% 96 $169.45
C9113 Injection, pantoprazole sodium, per vial <1% 143 $168.47
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 769 $166.65
90662 <1% 1,004 $161.65
90670 <1% 2,012 $159.65
70551 Magnetic resonance imaging, brain; without contrast material <1% 33 $150.20
86850 <1% 1,775 $145.26
J0780 Injection, prochlorperazine, up to 10 mg <1% 74 $144.44
87205 <1% 1,921 $143.83
76830 Ultrasound, transvaginal <1% 118 $132.74
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,585 $131.20
77065 Tomosynthesis, mammo <1% 13 $130.49
J0690 Injection, cefazolin sodium, 500 mg <1% 105 $127.89
88142 <1% 882 $124.47
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,681 $120.25
93242 <1% 28 $117.10
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 56 $115.12
86317 <1% 923 $115.06
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,591 $112.10
99225 <1% 56 $109.69
0064A <1% 452 $103.80
J1170 Injection, hydromorphone, up to 4 mg <1% 165 $102.23
82570 <1% 651 $99.84
51798 <1% 17 $99.23
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 38 $98.27
J0595 Injection, butorphanol tartrate, 1 mg <1% 47 $96.15
95251 <1% 36 $95.54
87340 <1% 1,801 $91.39
87503 <1% 529 $89.58
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 205 $86.56
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 74 $85.05
86618 <1% 1,020 $81.39
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 735 $78.53
A0426 Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) <1% 17 $73.60
J3411 Injection, thiamine hcl, 100 mg <1% 53 $72.21
87522 Neg quan hep c or qual rna <1% 268 $70.90
93793 <1% 59 $69.00
90686 <1% 4,578 $67.80
81025 <1% 7,049 $65.11
12001 <1% 66 $64.01
86704 <1% 856 $60.26
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 5,923 $58.37
83516 <1% 70 $55.61
82140 <1% 58 $54.94
80164 <1% 365 $54.90
G0008 Administration of influenza virus vaccine <1% 1,953 $54.42
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 340 $51.10
86708 <1% 814 $49.91
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,595 $49.15
82947 <1% 2,197 $45.98
80051 <1% 97 $44.27
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 193 $41.11
84165 <1% 55 $40.41
93246 <1% 13 $40.00
0352U <1% 179 $38.67
85018 <1% 838 $38.02
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,357 $37.93
80299 <1% 25 $35.79
90656 <1% 473 $34.74
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 96 $30.23
83970 <1% 67 $27.81
90632 <1% 15 $22.85
86038 <1% 192 $18.74
87493 <1% 14 $17.75
82077 <1% 159 $17.27
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 17 $15.81
87045 <1% 39 $15.32
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 12 $13.42
87046 <1% 39 $13.04
J2470 Injection, pantoprazole sodium, 40 mg <1% 17 $12.36
93244 <1% 27 $10.97
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 4,625 $10.00
84153 <1% 86 $9.98
85007 <1% 374 $9.64
0124A <1% 63 $9.63
80177 <1% 120 $9.43
85014 <1% 161 $9.22
90472 Immunization administration, each additional vaccine (list separately) <1% 3,987 $8.55
86592 <1% 1,046 $7.93
87478 <1% 378 $6.53
87468 <1% 379 $6.53
87484 <1% 378 $6.53
87469 <1% 379 $6.53
87427 <1% 13 $5.77
93248 <1% 13 $4.98
99406 <1% 72 $4.88
A4627 Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler <1% 493 $4.86
82784 <1% 67 $4.44
87210 <1% 204 $3.60
82105 <1% 118 $2.59
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 250 $2.54
86255 <1% 26 $2.35
80175 <1% 71 $1.87
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 902 $1.85
87185 <1% 27 $0.64
85651 <1% 74 $0.49
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 690 $0.22
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 1,455 $0.09
G0009 Administration of pneumococcal vaccine <1% 149 $0.06
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 429 $0.04
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 179 $0.04
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting <1% 24 $0.03
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 381 $0.03
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals <1% 144 $0.03
J0571 Buprenorphine, oral, 1 mg 0% 19 $0.00
90723 0% 397 $0.00
90651 0% 251 $0.00
90680 0% 287 $0.00
90697 0% 221 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 218 $0.00
70496 0% 15 $0.00
90480 0% 341 $0.00
86762 0% 67 $0.00
0134A 0% 133 $0.00
90647 0% 628 $0.00
90698 0% 218 $0.00
90696 0% 102 $0.00
0011A 0% 265 $0.00
80178 0% 18 $0.00
87147 0% 184 $0.00
90716 0% 54 $0.00
90732 0% 61 $0.00
85008 0% 45 $0.00
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 0% 13 $0.00
90744 0% 67 $0.00
87428 0% 50 $0.00
86706 0% 157 $0.00
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 0% 42 $0.00
74019 0% 14 $0.00
76801 0% 12 $0.00
0031A 0% 142 $0.00
0012A 0% 82 $0.00
87430 0% 75 $0.00
G0103 Prostate cancer screening; prostate specific antigen test (psa) 0% 14 $0.00
90677 0% 280 $0.00
E0112 Crutches underarm, wood, adjustable or fixed, pair, with pads, tips and handgrips 0% 15 $0.00
87081 0% 38 $0.00
87807 0% 83 $0.00
82390 0% 15 $0.00
J0574 Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine 0% 24 $0.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 0% 49 $0.00
86364 0% 14 $0.00
84702 0% 1,646 $0.00
99188 0% 297 $0.00
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 0% 4,147 $0.00
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 0% 410 $0.00
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 0% 6,535 $0.00
90460 Immunization administration through 18 years of age via any route, first or only component 0% 3,326 $0.00
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 17 $0.00
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 442 $0.00
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 0% 3,142 $0.00
83655 0% 1,018 $0.00
91322 0% 240 $0.00
90700 0% 108 $0.00
90461 0% 1,935 $0.00
90734 0% 282 $0.00
G2250 Remote assessment of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment 0% 13 $0.00
71271 0% 409 $0.00
90685 0% 120 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 691 $0.00
86787 0% 67 $0.00
90710 0% 229 $0.00
90633 0% 1,154 $0.00
82009 0% 60 $0.00
84145 0% 30 $0.00
86709 0% 67 $0.00
84146 0% 13 $0.00
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory 0% 98 $0.00
87631 0% 52 $0.00
84403 0% 27 $0.00
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 0% 183 $0.00
84550 0% 28 $0.00
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit 0% 29 $0.00
80143 0% 17 $0.00
84156 0% 16 $0.00
90681 0% 47 $0.00
S0164 Injection, pantoprazole sodium, 40 mg 0% 28 $0.00
S0028 Injection, famotidine, 20 mg 0% 79 $0.00
99382 0% 26 $0.00
90707 0% 41 $0.00
99001 0% 94 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 21 $0.00
91320 0% 21 $0.00
0034A 0% 16 $0.00
0013A 0% 13 $0.00
80179 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDOUCETTE, ELMER (CFO)
Same official

Other billing entities under DOUCETTE, ELMER

Full network →
ProviderLocationPaid
Redington-Fairview General HospitalMadison, ME$1.01M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.